Company page

Polynovo Limited

Polynovo Limited is a public company listed on the Australian market under the ticker PNV, with a market capitalization of approximately AUD 493.8 million. The company focuses on developing innovative medical devices, particularly in the field of regenerative medicine. Polynovo aims to improve patient outcomes through its advanced products and technologies.

profilePNV:ASXAI content: aiUpdated June 24, 2026/company/polynovo-ltd/c-8flilrfq
Polynovo Limited logo
Ticker
PNV:ASX
Asset type
Stock
Market cap
$493.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD